Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. (Record no. 26743509)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02232 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517132425.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201708s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1468-2060 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1136/annrheumdis-2016-210236 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Coghlan, John Gerry |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20170821 |
| 245 00 - TITLE STATEMENT | |
| Title | Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Annals of the rheumatic diseases |
| Date of publication, distribution, etc. | Jul 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1219-1227 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antihypertensive Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Progression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Edema |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hypertension, Pulmonary |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lupus Erythematosus, Systemic |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mixed Connective Tissue Disease |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenylpropionates |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phosphodiesterase 5 Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyridazines |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Scleroderma, Systemic |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tadalafil |
| General subdivision | therapeutic use |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Galiè, Nazzareno |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barberà, Joan Albert |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Frost, Adaani E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ghofrani, Hossein-Ardeschir |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hoeper, Marius M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kuwana, Masataka |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McLaughlin, Vallerie V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peacock, Andrew J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Simonneau, Gérald |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vachiéry, Jean-Luc |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blair, Christiana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gillies, Hunter |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Miller, Karen L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Harris, Julia H N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Langley, Jonathan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rubin, Lewis J |
| 773 0# - HOST ITEM ENTRY | |
| Title | Annals of the rheumatic diseases |
| Related parts | vol. 76 |
| -- | no. 7 |
| -- | p. 1219-1227 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1136/annrheumdis-2016-210236">https://doi.org/10.1136/annrheumdis-2016-210236</a> |
| Public note | Available from publisher's website |
No items available.